4 ms·
The phase 3 trial is where the safety and efficacy of a vaccine is determined for various groups. The risk/benefit decision you suggest can’t be made until it h
by jmull 6y ago
The phase 3 trial is where the safety and efficacy of a vaccine is determined for various groups. The risk/benefit decision you suggest can’t be made until it has been done.
It’s like the trolley problem but you don’t know whether more people will be killed if you throw the switch or not.
Also, if people are encouraged to take a vaccine that later turns out to have significant, previously unknown negative side effects, they will be less likely to take vaccines in the future. Squandered trust is very, very costly to regain so needs to be accounted for in a risk analysis.
- nfw2 6y agoThe data we have gives some information about the risks, although it not a completely clear picture. There is uncertainty, but any sort of risk/benefit analysis has to deal with uncertainty. I don't think OP is arguing that people be encouraged to take the vaccine, just that the option be made available to them if they want it. I don't think it would squander trust if it is explicitly repeated that the vaccine is not known to be effective yet and that there are still potential side effects, and the recipient acknowledges they understand.